Has Christopher Ellis, MD received payments from drug or device companies?

Yes. Drug and device makers reported $4,144,939 in general payments to Christopher Ellis, MD across 1,233 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Christopher Ellis, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Christopher Ellis, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Christopher Ellis, MD

Cardiovascular Disease · Nashville, TNNPI 1528174752

Payments from drug & device makers

$4,144,939in general payments, 2019–2025

Across 1,233 payments — averaging $3361.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$1.3M
Abbott$1.2M
Medtronic$659K
Boehringer Ingelheim$596K
Atricure, Inc.$259K
Biosense Webster, Inc.$56K
plus $29K from 10 others

What the payments were for

Consulting fees$281,70053%
Speaking & faculty fees$76,96515%
Travel & lodging$137,00726%
Food & beverage$31,2806%
Education$2500%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	388	$1,340,045
Abbott	549	$1,206,133
Medtronic(2 entities)	133	$659,032
Boehringer Ingelheim	16	$596,488
Atricure, Inc.	90	$258,607
Biosense Webster, Inc.	17	$55,624
Medical Device Business Services, Inc.	4	$20,520
Philips North America LLC	11	$4,294
Biotronik Inc.	17	$3,889
Microtransponder, Inc.	1	$123
Tactile Systems Technology Inc	2	$50
Siemens Medical Solutions USA, Inc.	1	$37
Acutus Medical, Inc.	1	$37
Bayer	1	$26
Cvrx, Inc.	1	$17
Altathera Pharmaceuticals LLC	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,144,939 in reported general payments places this provider in the 95th percentile of 429 cardiovascular disease providers in Tennessee.

See all cardiovascular disease providers in Tennessee →

Medicare billing

Part B allowed, 2024

$366,175

Medicare patients

1,819

Services billed

4,084

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	515	$688,280
XareltoRivaroxaban	79	$98,134
MultaqDronedarone Hcl	37	$63,736
Dofetilide	120	$23,358
EntrestoSacubitril/Valsartan	14	$11,862
Propafenone Hcl ErPropafenone Hcl	46	$7,074
Flecainide Acetate	101	$6,023
Metoprolol Succinate	260	$4,633
Amiodarone Hcl	203	$3,846
Propafenone Hcl	51	$3,357
Diltiazem 24hr Er (Cd)Diltiazem Hcl	97	$2,952
SotalolSotalol Hcl	80	$1,558
Bisoprolol Fumarate	16	$1,171
Potassium Chloride	34	$946
Warfarin Sodium	47	$728

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Nashville

Brian LindmanNashville$5.5M
Dinesh GuptaNashville$3.2M
Joann LindenfeldNashville$2.2M
Rebecca HungNashville$1.8M
Travis RichardsonNashville$1.3M
Mark ZenkerNashville$992K
Arvindh KanagasundramNashville$912K
Sandip ZalawadiyaNashville$647K
Pete FongNashville$621K
Macrae LintonNashville$572K

See the full list for Tennessee →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →